News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
World Health Organization: Further Investigation Needed into GlaxoSmithKline’s Pandemrix, Narcolepsy Link to Flu Shots Not Clear
February 9, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Genetic factors may have contributed to a spike in narcolepsy cases observed among children in Finland who received the swine flu vaccine Pandemrix, the World Health Organization said Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
GSK
MORE ON THIS TOPIC
IN PARTNERSHIP WITH GEMPHARMATECH
Beyond GLP‑1s: The race for next‑gen obesity drugs starts in the preclinical models
September 2, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Multiple sclerosis
Novartis’ Rhapsido cuts MS progression in Phase 3 trial, teeing up Roche battle
September 2, 2026
·
2 min read
·
Tristan Manalac
FDA
Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals
September 2, 2026
·
2 min read
·
Jef Akst
Cancer
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
September 1, 2026
·
2 min read
·
Annalee Armstrong
